It is alarming to see how the chronology of discovery can determine our perceptions, and blinker us against true perspective. This has been well illustrated by the acquired immune deficiency syndrome (AIDS) and its causative retrovirus human immunodeficiency virus (HIV), previously known as human T-lymphotropic virus type III or lymphadenopathy associated virus (HTLV-III/LAV)" 2. AIDS was first recognized in the USA in 1981, with the first cases being retrospectively diagnosed back to 1978. It was first identified in sexually active male homosexuals, but in 1982 other high-risk groups were noted including intravenous drug abusers, haemophiliacs and transfusion recipients; the disease was also seen in female sexual partners and children of AIDS patients.
The epidemiological pattern, together with the rapid rise in cases, strongly indicated that AIDS was due to an infectious agent that was sexually transmitted, but also transmitted by blood-to-blood contact and by maternofetal routes; a resemblance to hepatitis B virus transmission was noted. Most of this early epidemiology was derived from the USA, although similar cases were increasingly being recognized in Europe and elsewhere. Some observers placed much emphasis on particular aspects of homosexual intercourse, because of the very strong association with this form of sexual contact. Others saw the high prevalence of disease in sexually active gay men as a reflection oftheir more numerous sexual partners, both individually and as a community, as evidenced by their high frequency of other sexually transmitted infections. The identification of HIV as the causative agent of AIDS and associated disorders has greatly facilitated the study of the AIDS epidemic'. The physical fragility of the virus, due in particular to its lipid envelope, explains why such intimate contact is required for transmission to occur.
However, in Belgium and France an additional association was apparent, many patients being residents of Central Africa who had sought treatment in these ex-colonial countries (much of the literature on AIDS and Africa is well reviewed by Biggar3). Some cases were retrospectively diagnosed as far back as 1976, predating the first identifiable US cases. Epidemiologically, these African cases did not resemble US or endogenous European cases. A similar situation applied to cases seen among Haitians, but incomplete epidemiological information initially clouded that issue. Observations on Central African AIDS cases and subsequent seroepidemiological studies have demonstrated a strong association betweeen risk for the disease and having multiple heterosexual partners. In Haiti, a mixed picture emerged: sexual contact between US gay visitors and Haitian men linked the island with the US epidemic; the infection was then apparently passed to the female sexual partners and children of the Haitian men. Most evidence concerning Haiti indicated that the disease was new and was particularly seen in areas of prostitution. Subsequent studies have shown that the causative virus is not common in the rest of Haiti; this argues against the idea that Haiti was the source of the US epidemic and that the migration between Africa and Haiti caused intercontinental spread.
One might have expected that the evidence from Africa and Haiti, together with more limited evidence from North American and European cases, would have been accepted as clear indications that the causative virus of AIDS could spread through heterosexual contact. Yet, among many scientists as well as the lay public, that obvious conclusion has not always been drawn. Rather there has been a tendency to dismiss African evidence as uninterpretable or due to other confounding variables. The re-use of unsterilized equipment in paramedical activities and scarification have been blamed. Rumours have circulated about the use of anal intercourse as a common means of birth control in Africa; this idea represents a carry-over from the initial perceptions of AIDS as something intrinsically to do with homosexual behaviour. The widespread acceptance ofthese alternative explanations seems to indicate a remarkable ignorance about the countries in question; more disturbingly they have shown that many observers are unwilling to accept the obvious, if unpleasant, conclusion that AIDS, or rather HIV, is heterosexually transmitted.
If African countries had had the resources available in the USA during the mid-1970s, we would have seen AIDS emerging as a sexually transmitted disease, not dissimilar to syphilis. The epidemiological differences between the spread in the USA or Europe and that seen in Africa reflect the differing behavioural patterns in these regions. These have meant that the rate of rise of the African epidemic among heterosexuals has been as rapid as that among North American and European homosexuals; the much lower contact rate (as individuals and as communities) among North American and European heterosexuals has led to a much slower rate of rise. This is already evident on a small scale. Epidemiological tables only enumerate heterosexual AIDS cases who have had known sexual contact with infected persons; this is despite the fact that many in the so-called 'no known risk' group are heterosexuals with multiple sexual partners but without known AIDS contact4. It would be more logical to include these as a single group, comparable to homosexual/ bisexual males (for which group known contact is not a criterion). If this were to be done, 3-4% of the current case-load in North America and Europe would be seen to arise from heterosexual spread, representing 600-0 AIDS cases. Although the infection rate among heterosexuals is still very low in the 0141-0768/86/ 090501-03/$02.00/0 o 1986 The Royal Society of Medicine USA and Europe, current evidence, especially that from Africa, is already sufficiently strong to justify taking preventive action, mainly by educating sexually active heterosexuals about the risk of AIDS, before the prevalence rises any higher.
Some of the early seroepidemiology done in Central African countries used techniques that had not been validated with African sera, and it now appears that some of the results obtained were falsepositives. The idea that the virus has been widely prevalent in the African continent for decades does not now seem justified. It is, however, still likely that HIV first emerged in Africa, probably in people in remote regions with little contact, especially sexual contact, with other populations. The early studies gave rise to the notion that infection with HIV was not associated with much disease. Yet current experience in many Central African countries gives the lie to that. High current rates oftrue HIV seropositivity are matched by a formidable epidemic of disease that is at least as frequent an outcome of HIV infection as elsewhere. Countries already affected include Zaire, Rwanda, Burundi, Congo, Gabon, Central African Republic, Uganda, Tanzania, Zambia, and Kenya. The burden of infection and disease appears to be highest in the major cities and is generally associated with higher socioeconomic status and shows an age profile matching peak periods of sexual activity; in some countries there is an association with prostitution. A number of observations indicate that the emergence of HIV infection and AIDS are almost as recent in Africa as they are elsewhere, certainly on the present scale. While there has been an understandable quest for the origins of HIV, this remains a somewhat academic question. It has often been pursued with little thought for the implications of AIDS to the future of the region. The imminent medical, social and economic impact is only just beginning to be perceived.
A similar but distinct retrovirus (STLV-III) among old-world monkeys does not appear to be pathogenic for its host, although it can cause disease in other primates5. This has led to the suggestion that HIV is recently derived from the simian virus. This is obviously possible, although it is far from clear how recent 'recent' is. HIV could have been present, and even causing disease, in a human population in a remote rural region for some time, yet remaining undetected. It could then have been transmitted to others following the movements of peoples, especially to the urban areas ofAfrica. Its subsequent spread would reflect the existing modes ofsexual contact in these urban areas. This is analogous to the spread of HIV after its introduction into the cities of North America and Europe, revealing forms of contact that had evidently been present for many years. The new seed was thus propagated on the existing soil of human sexual behaviour. Whether the progress of HIV from subhuman primate to man will eventually be charted will depend upon the availability of suitable serum stores and on studies on existing rural peoples; it is likely to be some time before these essentially archaeological questions can satisfactorily be answered.
Recent observations have indicated the presence of at least one other retrovirus, one that is genetically closer to the simian virus, in human populations in West Africa (Senegal, Guinea Bissau and possibly Cameroon)6'9. Whether or not this virus, which has been called HTLV-IV or LAV-2, causes disease in humans is not yet clear; there is also uncertainty about the extent to which antibodies directed against it will cross-react with HIV in existing assay systems. They may also have important implications for the development of vaccines against HIV. The detection of these viruses, in the wake of the AIDS epidemic, is at an early stage; other more distant retroviruses may be more difficult to identify until we have the tools for their isolation. Until then, our knowledge is necessarily patchy. The retrovirus map of Africa, and indeed of the world, remains to be drawn. It is important to regard our current hypotheses about these viruses and their origins as provisional, lest we fall again into the trap of being blinkered by perceptions resulting from the chronology of their discovery.
The clinical profile of disease in Africa appears to be somewhat different in African AIDS patients as compared with that seen elsewhere. This is most evident in respect of the opportunist infections. The cellular immune defect in AIDS makes people susceptible to a range of organisms that are, for the most part, encountered early in life and that remain latent for life; they only re-emerge to cause disease when immune defences are lowered. The pattern of infection in AIDS thus reflects the previous microbial experience of the individual'0. Hence different patterns have been seen between Haiti and the USA, between the USA and Europe and, most strikingly, between Africa and other regions. The full profile of opportunist events in Africa remains to be established, but pneumocystis infection seems rare, while tuberculosis (both typical and atypical), cryptococcal, cryptosporidial and isospora infections are more common. The term 'Slim"' has emerged locally in Africa as an all too accurate description of the enteropathic form of AIDS, which is generally due to protozoal opportunist infection (A Bayley, personal communication). Malaria, and possibly other locally prevalent infections, may also behave as opportunists (personal observations).
Kaposi's sarcoma in Africa has been especially confusing. Classical African Kaposi's sarcoma occurs in a similar, but wider, geographical area than that now affected by AIDS. Evidence that it is associated with immunodeficiency is not strong12. although it is more so than the evidence concerning the classical form seen in Western countries among elderly people of Mediterranean or Ashkenazy Jewish extraction. On the other hand, Kaposi's sarcoma was seen, albeit infrequently, in patients who were deliberately immunosuppressed (e.g. for renal transplantation). Kaposi's sarcoma in AIDS in the USA and Europe is particularly, but not exclusively, found in the homosexual risk group. Many observers think that this, with other features, indicates that the opportunist tumour is due to an oncogenic virus that is more prevalent among gay men; evidence that it is cytomegalovirus is suggestive but not conclusive', but it is likely to be an organism that shows a similarly high prevalence among gay men. The Kaposi's sarcoma of African AIDS is a more aggressive tumour than the classical African form'3 and, interestingly, is also more aggressive than that seen amongst most Western AIDS cases. The former difference presumably reflects the fact that classical African Kaposi's sarcoma is not associated with such a severe cellular immunodeficiency as AIDS. The reasons for the latter difference are not yet apparent, but they may provide an important clinical clue about the causative agent(s) of Kaposi's sarcoma or about the immune profile of AIDS in Africa. Studies on the immunology and clinical features of the various forms of Kaposi's sarcoma, especially those occurring with and without HIV infection in Africa, will be most instructive as to the biology of this remarkable neoplasm. The report by Otu in this issue (p 510), for example, helps by showing that the monocyte defects previously reported in AIDS Kaposi's sarcoma14" 5 are also found in classical African Kaposi's sarcoma in Nigeria, which is not associated with HIV infection.
Other work in Africa will help to delineate many currently uncertain areas in AIDS research; these include the risk factors for heterosexual spread, the risks of maternofetal spread, the risk of AIDS among HIV-infected neonates and pregnant women, the role oftropical infections as co-factors for disease and the value of prophylaxis for opportunist infection. There is also an urgent need for work of specific relevance to Africa, such as developing-appropriate technology for early diagnosis of opportunist disease and establishing the natural history of AIDS in Africa, as a background to the almost inevitable need for a system of triage to cope with AIDS as it emerges on an increasingly large scale. If just 1% of those caring just for an elderly relative gave up, health and social service budgets would have to increase by 20% overnight; in fact, those caring for the elderly at home are saving the statutory services £5.3 billion a year, because the cost of a bed in a residential establishment is between £140 and £500 a week, while the maximum State Attendance Allowance (available only to the most severely disabled living at home) is £28.60 a week.
Anthony J Pinching
Carers range from as young as 4 to as old as 99; many elderly people are cared for by relatives who are themselves in their 70s and 80s.
One survey showed that 68% of carers are themselves in poor health, but most cannot seek treatment because there is no one to take over from them at home.
It is not just age that afflicts these families. The major problem is dementia, sometimes coming in its due season to the very old, sometimes because of Alzheimer's disease, which of course, can affect the comparatively young, and sometimes because of multi-infarcts, and bringing with it all its attendant miseries.
It is easy to feel tender and caring towards a person with an obvious physical disability like a broken leg; less easy to be tender when your much loved mother responds to your care with paranoid accusations of being robbed or poisoned, or wakes you up every night in the small hours to pack her bags so that she can 'go home', or forgets where the lavatory is and regularly soils your furniture and carpets as well as herself. And anyway, broken legs heal and the afflicted walk again and there is an end to your burden. The demented do not get better. The only remedy for the disease that has destroyed
